Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

Published:2010-06-28 Issue:1 Volume:10 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Raszeja-Wyszomirska Joanna,Szymanik Barbara,Ławniczak Małgorzata,Kajor Maciej,Chwist Alina,Milkiewicz Piotr,Hartleb Marek

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-10-67/fulltext.html

Reference15 articles.

1. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S: Risk of severe level disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008, 48: 792-798. 10.1002/hep.22429.

2. Tarantino G, Saldalamacchia G, Conca P, Arena A: Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007, 22: 293-303. 10.1111/j.1440-1746.2007.04824.x.

3. Tarher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day Ch, Arcaro G: Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007, 30: 1212-1218. 10.2337/dc06-2247.

4. Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwandet-Tetri BA: Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008, 57: 1441-1447. 10.1136/gut.2007.146019.

5. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TB, Day CP: The NAFLD Fibrosis Score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007, 45: 846-854. 10.1002/hep.21496.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants;Frontiers in Nutrition;2024-02-14

2. Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis;Journal of Clinical Medicine;2023-08-31

3. Determination of the Level of Cardiovascular Risk in 172,282 Spanish Working Women;Diagnostics;2023-08-23

4. Associations of non-invasive indices of liver steatosis and fibrosis with progressive kidney impairment in adults with type 2 diabetes;Acta Diabetologica;2023-03-21

5. The Link between NAFLD and Metabolic Syndrome;Diagnostics;2023-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3